AwardedSVNServices€1,100,000
Genomsko testiranje za načrtovanje zdravljenja zgodnjega raka dojke
- Published
- Published 25 February 2026
- Deadline
- Closed 30 March 2026
Overview
The Oncology Institute Ljubljana has awarded a contract for genomic testing services for early breast cancer treatment planning to DIAGENOMI and Med Gen-Sol Kft. The procurement, valued at 1,074,000 EUR, comprises two components: Oncotype DX testing and Mammaprint testing, and was completed on 12 May 2026.
Key details
- Country
- SVN
- Status
- Awarded
- Category
- Services
- Estimated value
- €1,100,000
- Procedure
- Open
- SME suitable
- No
- Published
- 25 February 2026
- Deadline
- Closed
Services provided by medical laboratories
Award outcome
- Awarded value
- €1,074,000
- Award date
- 12 May 2026
- Contract period
- — → 4 May 2028
- DIAGENOMI, znanstvena raziskovalna in razvojna dejavnost, d.o.o.
- Med Gen-Sol Kft
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 June 2026
Contract Notice
25 February 2026
Contracting authority
ONKOLOŠKI INŠTITUT LJUBLJANA
Procuring entityLjubljana, SVN
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.